Advanced search
Publication Cover
CNS Oncology Volume 13, 2024 - Issue 1
Submit an article Journal homepage
297
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Postradiation platinum–etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity

Edina Komlodi-Pasztor1 Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USA;4 Department of Neurology, Lombardi Cancer Center, MedStar Georgetown University Hospital, 3800 Reservoir Rd NW, Washington, DC 20007, USAView further author information
,
Vasu Munjapara1 Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USAView further author information
,
Charles G Eberhart2 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USAView further author information
,
Danielle A Bazer1 Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USAView further author information
,
Mohamed R Sherief1 Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USAView further author information
,
David Olayinka Kamson1 Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USAView further author information
,
Xiaobu Ye3 Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USAView further author information
,
Byram Hirsch Ozer1 Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USA;5 Neuro-Oncology Branch, National Institutes of Health-National Cancer Institute, Bethesda, MD 20892, USAView further author information
&
Matthias Holdhoff1 Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, 201 N Broadway, Baltimore, MD 21287, USA;3 Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3285-3484View further author information
ORCID Icon show all
Article: CNS107 | Received 11 Dec 2023, Accepted 19 Feb 2024, Published online: 08 Mar 2024

References

  • Ostrom QT, Gittleman H, Truitt G et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol. 20(Suppl. 4), iv1–iv86 (2018).
  • Franceschi E, Bartolotti M, Paccapelo A et al. Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients? J. Neurooncol. 128(2), 235–240 (2016).
  • Liu KX, Ioakeim-Ioannidou M, Susko MS et al. A multi-institutional comparative analysis of proton and photon therapy-induced hematologic toxicity in patients with medulloblastoma. Int. J. Radiat. Oncol. Biol. Phys. 109(3), 726–735 (2021). Epub 2020 Nov 23.
  • Brown AP, Barney CL, Grosshans DR et al. Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma. Int. J. Radiat. Oncol. Biol. Phys. 86(2), 277–284 (2013) ( Epub 2013 Feb 20).
  • Beier D, Proescholdt M, Reinert C et al. Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Neuro Oncol. 20(3), 400–410 (2018).
  • Majd N, Penas-Prado M. Updates on management of adult medulloblastoma. Curr. Treat. Options Oncol. 20(8), 64 (2019).
  • Majd NK, Mastall M, Lin H et al. Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome: the MD Anderson Cancer Center experience. Neurooncol. Adv. 3(1), vdab079 (2021).
  • Packer RJ, Gajjar A, Vezina G et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J. Clin. Oncol. 24(25), 4202–4208 (2006).
  • Taylor RE, Bailey CC, Robinson K et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study. J. Clin. Oncol. 21, 1581–1591 (2003).
  • National Comprehensive Cancer Network (NCCN) guidelines (2022). ( Version 2). www.nccn.org/
  • Franceschi E, Minichillo S, Mura A et al. Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study. BMC Cancer 20(1), 755 (2020).
  • Franceschi E, Hofer S, Brandes AA et al. EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. Lancet Oncol. 20(12), e715–e728 (2019).
  • Boyle FM, Eller SL, Grossman SA. Penetration of intra-arterially administered vincristine in experimental brain tumor. Neuro-Oncology 6(4), 300–306 (2004).
  • Mascaux C, Paesmans M, Berghmans T et al. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 30(1), 23–36 (2000).
  • Brandes AA, Ermani M, Amista P et al. The treatment of adults with medulloblastoma: a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 57(3), 755–761 (2003).
  • Brandes AA, Franceschi E, Tosoni A, Blatt V, Ermani M. Long-term results of a prospective study on the treatment of medulloblastoma in adults. Cancer 110(9), 2035–2041 (2007).
  • Friedrich C, von Bueren AO, von Hoff K et al. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. Eur. J. Cancer 49(4), 893–903 (2013).
  • Massimino M, Sunyach MP, Barretta F et al. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients. J. Neurooncol. 48(3), 619–628 (2020).
  • de Castria TB, da Silva EM, Gois AF, Riera R. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small-cell lung cancer. Cochrane Database Syst. Rev. (8), CD009256 (2013). Update in: Cochrane Database Syst Rev. 2020 Jan 13;1:CD009256 (2020).
  • Li Y, Song Q, Day BW. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis. Acta Neuropathol. Commun. 7(1), 123 (2019).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.